CUBE's goal is to push the envelope on innovation. Making change and innovation happen in the industry is a tough challenge that takes knowledge, creativity, time and also courage. No Equity. No obligations. No strings attached.
If your startup is outstanding, your products are desperately needed by the industry and the best of all qualifiers, CUBE will give you one million euros in cash.
Merck, a leading science and technology company, announced today the new startups participating in its Accelerator programs in Darmstadt, Germany and Nairobi, Kenya. The two program locations accept startups from different fields within Merck's core specialisms: Darmstadt takes startups from the fields of healthcare, life sciences and performance materials, while Nairobi works exclusively on innovations in digital healthcare. 
Siemens Healthineers and HeartFlow, Inc. have entered into a global collaboration agreement to provide a comprehensive, noninvasive solution to support the diagnosis and management of patients with suspected coronary artery disease (CAD). HeartFlow is a pioneer in personalized medical technology to aid in the diagnosis and treatment of CAD. 
Arthritis Research UK and IBM (NYSE: IBM) have announced the development of a Watson-powered 'virtual personal assistant' to provide information and advice to people living with arthritis. The charity has teamed up with IBM to ensure people seeking help will have access to personalised information from the Arthritis Research UK website, delivered in a form that feels like a natural conversation. 
LEO Innovation Lab is proud to announce that our CEO Kristian Hart-Hansen has won the eyeforpharma Customer Innovator Award. Kristian has spearheaded the growth of the LEO Innovation Lab since it's conception in 2015 with just six team members, to a thriving incubator of over 80 people and 15 projects today. The lab was established by LEO Pharma as an independent initiative to focus on using digital innovation to help individuals manage chronic skin conditions. 
German Accelerator Life Sciences (GALS) helps young German life science companies succeed in the global market. GALS provides individualized and highly flexible services, tailored towards the specific needs and objectives of startups and emerging companies in the life sciences. Experienced mentors and consultants work with the participating teams to establish networks of potential clients, partners, and investors.